Breaking News
Get 50% Off 0
Get a powerful boost to your portfolio: August's freshest AI-picked stocks
Pick Stocks with AI
Close

Vivoryon Therapeutics NV (05Y)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.404 0.000    0.00%
01/08 - Delayed Data. Currency in EUR
Type:  Equity
Market:  Germany
ISIN:  NL00150002Q7 
S/N:  A2QJV6
  • Volume: 0
  • Bid/Ask: 1.400 / 1.430
  • Day's Range: 1.404 - 1.404
Vivoryon Therapeutics 1.404 0.000 0.00%

05Y Recent Sentiments

 
This page features our user's sentiments regarding the Vivoryon Therapeutics NV share. They are displayed on both charts of different time periods and in a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Jul 15, 2025 Rolf Allerding   1.432 -1.96%
Jun 25, 2025 Antonio Requena   1.454 Jun 30, 2025 @ 1.446 +0.55%
Dec 17, 2024 Piotr Kuczmarski   1.970 Jan 10, 2025 @ 2.020 +2.54%
Dec 10, 2024 Krzysztof Dekanski   2.045 Jan 03, 2025 @ 2.130 +4.16%
Dec 09, 2024 Panos Siniorakis   2.400 Jan 03, 2025 @ 2.130 -11.25%
Dec 09, 2024 John Klemmer   2.520 Jan 03, 2025 @ 2.130 -15.48%
Dec 09, 2024 Alexis Luna   2.360 Dec 16, 2024 @ 1.940 -17.80%
Dec 06, 2024 andres riq   1.828 Dec 27, 2024 @ 2.080 -13.79%
Dec 02, 2024 Gabriel Henríquez...   1.976 Dec 02, 2024 @ 1.874 -5.16%
Nov 14, 2024 Patryk Kepke   2.050 Dec 06, 2024 @ 1.828 -10.83%
Oct 25, 2024 Rolf Allerding   2.425 Nov 15, 2024 @ 2.030 +16.29%
Oct 23, 2024 lukass498   2.430 Nov 15, 2024 @ 2.030 -16.46%
Jul 18, 2024 Enes Pain   2.630 Aug 09, 2024 @ 2.145 -18.44%
Jul 18, 2024 Elke Zulauf   2.660 Aug 09, 2024 @ 2.145 -19.36%
Jul 05, 2024 Andreas Höfler   1.874 Jul 26, 2024 @ 2.480 +32.34%
Jun 27, 2024 Andy Bock   1.800 Jul 19, 2024 @ 2.350 +30.56%
Jun 24, 2024 Mustafa Maman   1.938 Jul 19, 2024 @ 2.350 +21.26%
Jun 18, 2024 Felix Schiffmann   1.902 Jun 18, 2024 @ 1.902 0.00%
Apr 22, 2024 Rolf Allerding   0.582 May 17, 2024 @ 0.814 +39.86%
Mar 04, 2024 Martin Jurtz   0.777 Mar 29, 2024 @ 0.533 -31.40%
Mar 04, 2024 pasquale dibattista   0.600 Mar 05, 2024 @ 0.760 +26.67%
Mar 04, 2024 Rolf Allerding   1.900 Mar 29, 2024 @ 0.533 -71.95%
Feb 09, 2024 Lars Zeißeweis   8.600 Feb 29, 2024 @ 8.720 +1.40%
Feb 09, 2024 Lars Zeißeweis   8.600 Feb 09, 2024 @ 8.600 0.00%
Jan 29, 2024 martin wiesenhuetter   9.200 Feb 23, 2024 @ 9.000 -2.17%
Dec 12, 2023 Ergün Kop   7.390 Jan 05, 2024 @ 7.780 +5.28%
Feb 20, 2023 Hendrik Doliner   15.500 Mar 17, 2023 @ 14.320 -7.61%
Nov 30, 2022 Hendrik Doliner   9.200 Dec 23, 2022 @ 10.420 +13.26%
Jan 07, 2021 Nathalie Mertz   11.260 Jan 29, 2021 @ 13.960 +23.98%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

VVY Comments

Write your thoughts about Vivoryon Therapeutics NV
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email